| Literature DB >> 27833098 |
Yiyong Liu1, Durai Sellegounder1, Jingru Sun1.
Abstract
Upon pathogen infection, microbial killing pathways and cellular stress pathways are rapidly activated by the host innate immune system. These pathways must be tightly regulated because insufficient or excessive immune responses have deleterious consequences. Increasing evidence indicates that the nervous system regulates the immune system to confer coordinated protection to the host. However, the precise mechanisms of neural-immune communication remain unclear. Previously we have demonstrated that OCTR-1, a neuronal G protein-coupled receptor, functions in the sensory neurons ASH and ASI to suppress innate immune responses in non-neural tissues against Pseudomonas aeruginosa in Caenorhabditis elegans. In the current study, by using a mass spectrometry-based quantitative proteomics approach, we discovered that OCTR-1 regulates innate immunity by suppressing translation and the unfolded protein response (UPR) pathways at the protein level. Functional assays revealed that OCTR-1 inhibits specific protein synthesis factors such as ribosomal protein RPS-1 and translation initiation factor EIF-3.J to reduce infection-triggered protein synthesis and UPR. Translational inhibition by chemicals abolishes the OCTR-1-controlled innate immune responses, indicating that activation of the OCTR-1 pathway is dependent on translation upregulation such as that induced by pathogen infection. Because OCTR-1 downregulates protein translation activities, the OCTR-1 pathway could function to suppress excessive responses to infection or to restore protein homeostasis after infection.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27833098 PMCID: PMC5104976 DOI: 10.1038/srep36832
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scheme of label-free quantitative proteomics.
Synchronized animals at L4 stage were either fed E. Coli OP50 (uninfected controls) or P. aeruginosa PA14 (infected samples) for 4 hr, collected, and lysed. Total proteins were extracted and digested with trypsin. Peptides from control or infected samples were subject to nano-HPLC tandem MS analysis. Quantification is based on the comparison of peak intensity of same peptides in different samples.
P. aeruginosa-induced proteins in wild-type N2 animals.
| Functional Group | Protein | Gene ID | Fold Change | p-Value | Overlap with published microarray data | ||
|---|---|---|---|---|---|---|---|
| Troemel | Shapira | Evan | |||||
| CUB-like domain | DOD-24 | only in the infected | x | x | |||
| F55G11.2 | 10.1 | 7.58E-03 | x | x | x | ||
| F55G11.4 | only in the infected | ||||||
| C32H11.4 | only in the infected | x | x | x | |||
| DOD-17 | only in the infected | x | x | ||||
| C17H12.8 | only in the infected | x | x | ||||
| C-type lectin | CLEC-63 | 3.4 | 1.11E-04 | ||||
| CLEC-66 | only in the infected | x | x | ||||
| Lysozyme | LYS-2 | only in the infected | x | ||||
| LMP-1 | only in the infected | ||||||
| ShK toxin domain | C14C6.5 | only in the infected | x | x | |||
| GST | GST-38 | only in the infected | x | x | |||
| Proteolysis/hydrolysis | ASP-14 | 3.4 | 5.97E-04 | x | x | ||
| M60.2 | only in the infected | x | |||||
| BRE-1 | 2.3 | 1.18E-03 | |||||
| HEX-1 | only in the infected | ||||||
| CAT-4 | only in the infected | ||||||
| B0222.5 | only in the infected | ||||||
| oxidoreductases | F20D6.11 | only in the infected | x | ||||
| VNA | 1.8 | 5.72E-03 | |||||
| C55A6.4 | only in the infected | ||||||
| GLRX-5 | 3.3 | 4.56E-03 | |||||
| F53C11.3 | 5.1 | 2.63E-03 | x | x | |||
| DAF-22 | 1.9 | 7.01E-03 | x | ||||
| MAOC-1 | 2.0 | 2.93E-03 | x | ||||
| Heat shock protein | Y55F3BR.6 | 2.0 | 2.25E-03 | ||||
| DNJ-19 | 3.1 | 2.28E-03 | |||||
| Development | NASP-2 | 2.5 | 6.75E-03 | ||||
| Y71F9AL.9 | 2.3 | 5.39E-03 | |||||
| CPG-2 | 2.1 | 6.37E-03 | |||||
| MLC-4 | 2.2 | 2.14E-03 | |||||
| VPS-32.1 | 2.7 | 4.38E-03 | |||||
| T23D8.3 | only in the infected | ||||||
| RMD-1 | only in the infected | ||||||
| SEC-24.2 | 2.1 | 6.44E-03 | |||||
| MRPL-34 | only in the infected | ||||||
| Others or unknown | DSC-4 | 1.8 | 9.23E-03 | ||||
| CEY-4 | 1.7 | 4.01E-04 | |||||
| ZC247.1 | 1.7 | 4.37E-03 | |||||
| PQN-59 | 1.7 | 6.29E-03 | |||||
| PUD-2.1 | 2.6 | 4.85E-05 | |||||
| Y44A6D.2 | 1.8 | 1.59E-03 | |||||
| Y69A2AR.18 | 1.7 | 8.28E-03 | |||||
| VDAC-1 | only in the infected | ||||||
| CLEC-209 | only in the infected | ||||||
| C15C7.5 | 4.3 | 5.37E-04 | |||||
| W05H9.1 | 2.1 | 3.93E-03 | |||||
| GLB-1 | 3.0 | 5.27E-03 | x | ||||
| ZK418.9 | 1.8 | 4.27E-03 | |||||
| LPD-8 | 2.1 | 1.34E-03 | |||||
| SNA-1 | only in the infected | ||||||
| IRG-3 | only in the infected | x | x | ||||
| LBP-4 | 2.1 | 8.12E-03 | |||||
#Only in the infected: the protein was only detected in the infected animals, not in the uninfected animals.
*Troemel et al. 2006 PLoS Genet 2(11):183; Shapira et al. 2006 Proc Natl Acad Sci USA 103(38):14086–14091; Evans et al. 2008 PLoS Pahtog 4(10):e1000175.
GO term (biological process) enrichment analysis of P. aeruginosa-induced proteins in wild-type N2 animals.
| GO term | Description | P-value[ | FDR q-value[ | Enrichment (N, B, n, b)[ |
|---|---|---|---|---|
| GO:0002376 | immune system process | 1.25E-11 | 2.63E-08 | 9.28 (1098, 36, 46, 14) |
| GO:0006955 | immune response | 1.25E-11 | 1.32E-08 | 9.28 (1098, 36, 46, 14) |
| GO:0045087 | innate immune response | 1.25E-11 | 8.77E-09 | 9.28 (1098, 36, 46, 14) |
| GO:0006952 | defense response | 7.98E-11 | 4.19E-08 | 7.46 (1098, 48, 46, 15) |
| GO:0006950 | response to stress | 7.15E-08 | 3.00E-05 | 3.91 (1098, 110, 46, 18) |
| GO:0050829 | defense response to Gram-negative bacterium | 2.03E-07 | 7.08E-05 | 12.85 (1098, 13, 46, 7) |
| GO:0050896 | response to stimulus | 2.27E-07 | 6.79E-05 | 3.64 (1098, 118, 46, 18) |
| GO:0043207 | response to external biotic stimulus | 1.23E-06 | 3.22E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0098542 | defense response to other organism | 1.23E-06 | 2.86E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0042742 | defense response to bacterium | 1.23E-06 | 2.57E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0009617 | response to bacterium | 1.23E-06 | 2.34E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0009607 | response to biotic stimulus | 1.23E-06 | 2.15E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0051707 | response to other organism | 1.23E-06 | 1.98E-04 | 10.44 (1098, 16, 46, 7) |
| GO:0009605 | response to external stimulus | 3.87E-05 | 5.80E-03 | 6.68 (1098, 25, 46, 7) |
| GO:0051704 | multi-organism process | 4.65E-04 | 6.50E-02 | 3.64 (1098, 59, 46, 9) |
#P-value is the enrichment p-value computed according to the mHG model (Eden et al. 2007 PLos Comp Bio 3(3):e39).
*FDR q-value is the correction of the above p-value for multiple testing using the Benjamini and Hochberg method (Benjamini and Hochberg 1995 J R Statist Soc B 57(1):289–300).
§Enrichment (N, B, n, b) is defined as follows:
N - is the total number of proteins.
B - is the total number of proteins associated with a specific GO term.
n - is the number of proteins in the target set.
b - is the number of proteins in the intersection.
Enrichment = (b/n)/(B/N).
P. aeruginosa-induced proteins in octr-1(ok371) animals.
| Biological Functions | Protein | Gene ID | Description | Fold Change | p-Value |
|---|---|---|---|---|---|
| Innate immune response | DOD-24 | CUB-like domain | infected only | ||
| F55G11.2 | CUB-like domain | infected only | |||
| F55G11.4 | CUB-like domain | infected only | |||
| C32H11.4 | CUB-like domain | infected only | |||
| DOD-17 | CUB-like domain | infected only | |||
| CLEC-67 | C-type lectin | infected only | |||
| CLEC-66 | C-type lectin | infected only | |||
| CLEC-63 | C-type lectin | 3.5 | 6.05E-03 | ||
| SKPO-1 | ShK toxin domain | infected only | |||
| C14C6.5 | ShK toxin domain | infected only | |||
| LYS-2 | lysozyme | infected only | |||
| GST-38 | glutathione S-transferase | infected only | |||
| GST-5 | glutathione S-transferase | 9.5 | 6.98E-03 | ||
| GST-4 | glutathione S-transferase | 2.8 | 9.81E-03 | ||
| GST-7 | glutathione S-transferase | 3.9 | 9.31E-03 | ||
| GCS-1 | glutathione biosynthesis | 2.7 | 8.72E-03 | ||
| ASP-14 | aspartyl protease | 7.2 | 5.77E-03 | ||
| M60.2 | ortholog of human endonuclease, polyU-specific | infected only | |||
| C17H12.8 | involved in innate immune response | infected only | |||
| F35E12.6 | involved in innate immune response | infected only | |||
| IRG-3 | infection response protein | infected only | |||
| SKR-3 | skp1 related (ubiquitin ligase complex component) | 2.3 | 6.32E-03 | ||
| DJR-1.1 | glutathione-independent glyoxalase DJR-1.1 | 1.8 | 2.25E-03 | ||
| Sulfur amino acid biosynthesis | METR-1 | probable methionine synthase | infected only | ||
| C01G10.9 | methylthioribose-1-phosphate isomerase | infected only | |||
| F58H1.3 | enolase-phosphatase E1 | 2.5 | 8.81E-05 | ||
| SAMS-4 | probable S-adenosylmethionine synthase 4 | 1.8 | 9.82E-03 | ||
| CTH-2 | putative cystathionine gamma-lyase 2 | 4.1 | 6.44E-03 | ||
| CYSL-2 | bifunctional L-3-cyanoalanine synthase/cysteine synthase | 2.3 | 1.71E-04 | ||
| HMG-11 | predicted to have DNA binding activity | infected only | |||
| Translation/protein synthesis | RPL-18 | 60S ribosomal protein L18 | 2.1 | 5.23E-03 | |
| RPS-10 | ribosomal protein, small subunit | 2.1 | 5.22E-03 | ||
| RPL-13 | 60S ribosomal protein L13 | 2.0 | 7.94E-03 | ||
| RPS-11 | ribosomal protein, small subunit | 1.7 | 7.59E-03 | ||
| RPS-1 | 40S ribosomal protein S3a | 1.6 | 8.48E-03 | ||
| RPS-28 | 40S ribosomal protein S28 | 1.4 | 9.56E-03 | ||
| MRPL-12 | mitochondrial ribosomal protein, large | 2.5 | 5.09E-03 | ||
| RUVB-1 | RuvB-like 1 | infected only | |||
| EIF-3.J | eukaryotic initiation factor | 1.7 | 4.35E-03 | ||
| K07C5.4 | ortholog of human NOP56 ribonucleoprotein | 1.5 | 9.73E-03 | ||
| SRP-6 | serpin (serine protease inhibitor) | infected only | |||
| proteolysis/hydrolysis | KLO-1 | KLOtho (mammalian aging-associated protein) homolog | 2.6 | 1.74E-03 | |
| F13H6.3 | ortholog of human carboxylesterase 2 | 2.3 | 4.69E-03 | ||
| TAX-6 | Serine/threonine-protein phosphatase | 2.0 | 8.34E-03 | ||
| Y25C1A.13 | ortholog of human enoyl CoA hydratase 1 | 2.0 | 9.29E-03 | ||
| PAM-1 | puromycin-sensitive aminopeptidase | 1.8 | 2.09E-03 | ||
| T22C1.6 | ortholog of human taxilin α, β, and γ | infected only | |||
| ER/UPR | Y41C4A.11 | involved in ER UPR | 4.3 | 1.84E-03 | |
| C14B9.2 | probable protein disulfide-isomerase A4 | 2.3 | 1.52E-03 | ||
| HSP-4 | heat shock protein | 2.2 | 2.00E-03 | ||
| PDI-1 | protein disulfide isomerase | 1.6 | 8.26E-03 | ||
| SNA-1 | snRNP-binding protein | infected only | |||
| Transcription | HRP-1 | putative hnRNP | 5.5 | 6.47E-05 | |
| T13F2.2 | predicted to have transcription coactivator activity | 3.3 | 1.74E-03 | ||
| RPB-2 | RNA polymerase II (B) subunit | 3.1 | 3.22E-05 | ||
| RPB-9 | RNA polymerase II (B) subunit | 2.5 | 6.86E-03 | ||
| CEY-4 | 2.0 | 1.05E-04 | |||
| CEY-2 | 1.7 | 3.55E-03 | |||
| CPG-2 | chondroitin proteoglycan | infected only | |||
| Development/reproduction | C29E4.12 | ortholog of human C7orf55 | infected only | ||
| Y18D10A.9 | ortholog of human CIAO1 | infected only | |||
| T23D8.3 | ortholog of human and yeast LTV1 | infected only | |||
| K07H8.10 | predicted to have necleic acid and nucleotide binding activity | 8.2 | 1.56E-05 | ||
| F55B11.2 | development | 4.4 | 9.81E-03 | ||
| DNC-2 | dynactin complex component | 3.2 | 3.30E-03 | ||
| F32A11.3 | involved in reproduction | 3.2 | 9.82E-03 | ||
| Y71F9AL.9 | ortholog of human SPATS2L and SPATS2 | 2.1 | 4.21E-04 | ||
| DPY-30 | dosage compensation protein | 2.0 | 4.34E-03 | ||
| PRX-19 | Peroxisome assembly factor | 1.9 | 9.17E-03 | ||
| MRPS-28 | Mitochondrial ribosomal Protein | 1.8 | 1.63E-03 | ||
| C44E4.4 | ortholog of human Sjogren syndrome atigen B | 1.6 | 7.28E-03 | ||
| F20D6.11 | putative FAD-binding oxidoreductase | infected only | |||
| Cell redox homeostasis | F29C4.2 | ortholog of human cytochrome c oxidase subunit Vic | infected only | ||
| Y47G6A.21 | predicted to have oxidoreductase activity | 2.8 | 1.91E-03 | ||
| F45H10.3 | predicted to have NADH dehydrogenase (ubiquinone) activity | 2.6 | 7.79E-03 | ||
| PRDX-6 | preoxiredoxin 6 | 1.7 | 6.03E-03 | ||
| KIN-10 | protein kinase | infected only | |||
| Protein Kinase | CAT-4 | GTP cyclohydrolase 1 | infected only | ||
| MMCM-1 | methylmalonyl-CoA mutase homolog | 5.4 | 4.87E-03 | ||
| compound metabolic process | C36A4.4 | probable UDP-N-acetylglucosamine pyrophosphorylase | 2.7 | 4.17E-03 | |
| C39D10.7 | involved in chitin metabolic process | 2.0 | 6.91E-03 | ||
| ZK1307.8 | ortholog of human protein kinase C substrate 80K-H | 1.8 | 8.37E-03 | ||
| CTS-1 | citrate synthase | 1.7 | 4.81E-03 | ||
| DPYD-1 | dihydropyrimidine dehydrogenase | 1.7 | 5.14E-03 |
#Infected only: the protein was only detected in the infected animals, not in the uninfected animals.
Figure 2qRT-PCR analysis of gfp gene expression in Phsp-4::GFP(zcls4) and octr-1(ok371);Phsp-4::GFP(zcls4) animals exposed to P. aeruginosa.
Relative fold-changes for gfp transcripts were normalized to pan-actin (act-1, -3, -4). Phsp-4::GFP(zcls4) versus octr-1(ok371);Phsp-4::GFP(zcls4), p = 0.07. Bars represent mean ± SEM. n = 3 independent experiments.
Figure 3Protein synthesis factors are involved in the OCTR-1-depedent immunity.
(A) Wild-type and octr-1(ok371) animals grown on double-stranded RNA (dsRNA) for vector control or dsRNA for rps-1 were exposed to P. aeruginosa PA14 and scored for survival over time. WT+ vector versus WT+rps-1 RNAi: p = 0.0386; octr-1(ok371)+vector versus octr-1(ok371)+rps-1 RNAi: p < 0.0001. Shown is a representative assay of three independent experiments. n = 45 young adult animals per strain. Significant knockdown of rps-1 expression by RNAi was confirmed by qRT-PCR (p < 0.001, Figure S2A). (B) Wild-type and octr-1(ok371) animals grown on dsRNA for vector control or dsRNA for eif-3.j were exposed to P. aeruginosa PA14 and scored for survival over time. WT+vector versus WT+eif-3.j RNAi: p = 0.4873; octr-1(ok371)+vector versus octr-1(ok371)+ eif-3.j RNAi: p = 0.0001. Shown is a representative assay of three independent experiments. n = 45 young adult animals per strain. p values < 0.05 are considered significant. Significant knockdown of eif-3.j expression by RNAi was confirmed by qRT-PCR (p < 0.001, Figure S2B).
Figure 4Knockdown of rps-1 or eif-3.j by RNAi reduces the XBP-1-dependent UPR in octr-1 mutant animals.
(A) Images of octr-1(ok371);Phsp-4::GFP(zcls4) animals. Animals were grown on double-stranded RNA for vector control or dsRNA for rps-1 or eif-3.j, and young adult animals were exposed to P. aeruginosa PA14. Animals that best represent the fluorescence level of the population were shown. (B) GFP quantification of octr-1(ok371);Phsp-4::GFP(zcls4) animals exposed to P. aeruginosa PA14. Binary mean intensity of the region of interest (ROI) that corresponds to an entire animal was measured by Image J software. n = 10–20 animals, error bars represent SEM. A two-sample t test was performed to compare the fluorescence intensity between populations. rps-1 RNAi versus control RNAi: p = 6.1 × 10−10; eif-3.j RNAi versus control RNAi: p = 4.8 × 10−7. p values < 0.05 are considered significant. Significant knockdown of rps-1 or eif-3.j expression by RNAi was confirmed by qRT-PCR (p < 0.001, Figure S3).
Figure 5Translational inhibition abolishes the OCTR-1-controlled innate immune responses.
(A) qRT-PCR of abu-1, abu-7, abu-8, abu-12, abu-13, abu-14, and abu-15 expression in wild-type animals with or without exposure to G418 and in octr-1(ok371) animals exposed to G418. n = 3; bar graphs correspond to mean ± SEM. t-tests were performed between N2 + G418 and octr-1 + G418. *indicates significant difference. (B) qRT-PCR of abu-1, abu-7, abu-8, abu-12, abu-13, abu-14, and abu-15 expression in wild-type animals with or without exposure to Hygrocymin B and in octr-1(ok371) animals exposed to Hygromycin B. n = 3; bar graphs correspond to mean ± SEM. t-tests were performed between N2 + G418 and octr-1 + G418. *indicates significant difference. (C) Wild-type and octr-1(ok371) animals were exposed to NGM/E. coli OP50 (control) or NGM/E. coli OP50 containing G418 or Hygromycin B, and scored for survival over time. WT + No inhibitor versus octr-1(ok371)+No inhibitor: p = 0.7521; WT + G418 versus octr-1(ok371)+G418: p < 0.0001; WT + Hygromycin B versus octr-1(ok371)+Hygromycin B: p < 0.0001. Shown is a representative assay of two independent experiments. n = 45 young adult animals per strain. p values < 0.05 are considered significant.